Ameriprise’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9M | Buy |
1,588,198
+106,389
| +7% | +$2.21M | 0.01% | 1082 |
|
|
2025
Q1 | $25.7M | Buy |
1,481,809
+61,757
| +4% | +$1.07M | 0.01% | 1167 |
|
|
2024
Q4 | $38.5M | Buy |
1,420,052
+322,601
| +29% | +$8.75M | 0.01% | 973 |
|
|
2024
Q3 | $48.2M | Buy |
1,097,451
+690,607
| +170% | +$30.3M | 0.01% | 870 |
|
|
2024
Q2 | $16M | Buy |
406,844
+316,187
| +349% | +$12.4M | ﹤0.01% | 1412 |
|
|
2024
Q1 | $3.89M | Buy |
90,657
+27,900
| +44% | +$1.2M | ﹤0.01% | 2520 |
|
|
2023
Q4 | $2.56M | Buy |
+62,757
| New | +$2.56M | ﹤0.01% | 2754 |
|